Brief: Synaffix Elevation Oncology Licenses ADC Technology From Synaffix To Drive Pipeline Expansion
Dec 12 (Reuters) - Elevation Oncology ELEV.O :
* SYNAFFIX: ELEVATION ONCOLOGY LICENSES ADC TECHNOLOGY FROM
SYNAFFIX TO DRIVE PIPELINE EXPANSION
* SYNAFFIX: CO IS ELIGIBLE TO RECEIVE UP TO $368 MILLION IN
UPFRONT AND CLINICAL, REGULATORY, AND COMMERCIAL MILESTONE
PAYMENTS
Source text: ID:nPre2N2L2a
Further company coverage: ELEV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Elevation Oncology
See all newsBrief: Elevation Oncology Terminates License Agreement With CSPC Megalith Biopharmaceutical
U.S. RESEARCH ROUNDUP- Crane, Ryder System, Terex
Brief: Elevation Oncology Says Concentra To Buy Elevation Oncology For $0.36 Per Share Plus CVR
Elevation Oncology Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Elevation Oncology Inc - To Prepay Term Loan Under Loan & Security Agreement Dated July 27, 2022 - SEC Filing